These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 24125194)

  • 41. Tolerance to incompatible ABO blood group antigens is not observed following homograft implantation.
    Feingold B; Raval JS; Galambos C; Yazer M; Zeevi A; Bentlejewski C; Morell VO; Wearden PD; Webber SA
    Hum Immunol; 2011 Oct; 72(10):835-40. PubMed ID: 21712059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation.
    Fan X; Ang A; Pollock-Barziv SM; Dipchand AI; Ruiz P; Wilson G; Platt JL; West LJ
    Nat Med; 2004 Nov; 10(11):1227-33. PubMed ID: 15502841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
    Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
    Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Administration of haptoglobin in ABO incompatible bone marrow transplantation].
    Ito M; Imoto S; Nakagawa T; Kai S; Hara H
    Rinsho Ketsueki; 1990 Oct; 31(10):1716-20. PubMed ID: 2255063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?
    Gutiérrez-Aguirre CH; Gómez-De-León A; Alatorre-Ricardo J; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; Mancías-Guerra C; Flores-Jiménez JA; Gómez-Almaguer D
    Transfusion; 2014 May; 54(5):1269-77. PubMed ID: 24898453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Donor- and recipient-derived immunity in ABO incompatible living-related liver transplantation.
    Schumann A; Fiedler M; Beckebaum S; Cicinnati VR; Herzer K; Lenz V; Witzke O; Paul A; Roggendorf M; Horn PA; Lindemann M
    Hum Immunol; 2015 Sep; 76(9):631-5. PubMed ID: 26394233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exchange living donor liver transplantation to overcome ABO incompatibility in adult patients.
    Hwang S; Lee SG; Moon DB; Song GW; Ahn CS; Kim KH; Ha TY; Jung DH; Kim KW; Choi NK; Park GC; Yu YD; Choi YI; Park PJ; Ha HS
    Liver Transpl; 2010 Apr; 16(4):482-90. PubMed ID: 20222052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of allogeneic blood group A and B enzyme activities in patients with ABO incompatible kidney transplantation.
    Tasaki M; Nakajima T; Imai N; Nakagawa Y; Saito K; Takahashi K; Yazawa S
    Glycobiology; 2010 Oct; 20(10):1251-8. PubMed ID: 20542872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful ABO-incompatible heart transplantation in a child despite blood-group sensitization after ventricular assist device support.
    Urschel S; Dalla Pozza R; Loeff M; Schmitz C; Sodian R; Schmoeckel M; Kowalski C; Netz H
    Pediatr Transplant; 2009 Sep; 13(6):773-6. PubMed ID: 19170929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
    Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Bone marrow transplantation with major ABO incompatibility. Experience at the bone marrow transplantation unit of the Center of Lisbon at the IPOFG].
    Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
    Acta Med Port; 1993 Feb; 6(2):79-81. PubMed ID: 8488766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.
    Cunard R; Marquez II; Ball ED; Nelson CL; Corringham S; Clopton P; Sanchez AP; Lane T; Ward DM
    Transfusion; 2014 Jul; 54(7):1857-63. PubMed ID: 24372185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulation.
    Sheppard D; Tay J; Bryant A; McDiarmid S; Huebsch L; Tokessy M; Hamelin L; Saidenberg E; Bredeson C
    Bone Marrow Transplant; 2013 Jul; 48(7):953-7. PubMed ID: 23334277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelial chimerism after ABO-incompatible kidney transplantation.
    Tanabe T; Ishida H; Horita S; Honda K; Yamaguchi Y; Nonomura K; Tanabe K
    Transplantation; 2012 Apr; 93(7):709-16. PubMed ID: 22456486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
    Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
    Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting antibody-mediated rejection in the setting of ABO-incompatible infant heart transplantation: graft accommodation vs. B cell tolerance.
    West LJ
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Jun; 5(3):223-32. PubMed ID: 15975036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delayed erythropoiesis after major ABO-incompatible bone marrow transplantation: report of a case.
    Tang JL; Lin MT; Wang CH; Lin DT; Chen YC
    J Formos Med Assoc; 1990 Oct; 89(10):892-5. PubMed ID: 1981778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of recipient ABH secretor status on outcome in minor ABO-incompatible hematopoietic stem cell transplantation.
    Holbro A; Stern M; Infanti L; O'Meara A; Drexler B; Frey BM; Tiercy JM; Passweg JR; Gassner C; Buser A; Sigle JP
    Transfusion; 2015 Jan; 55(1):64-9. PubMed ID: 24990435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serological complications of a major ABO incompatible bone marrow transplantation in a Polynesian with aplastic anemia.
    Ockelford PA; Hill RS; Nelson L; Blacklock HA; Woodfield DG; Matthews JR
    Transfusion; 1982; 22(1):62-5. PubMed ID: 7039010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.